Your browser doesn't support javascript.
loading
CD19/CD22 bispecific chimeric antigen receptor­NK­92 cells are developed and evaluated.
Kim, Hyori; Han, Mina; Kim, Minsong; Kim, Hyeri; Im, Ho Joon; Kim, Nayoung; Koh, Kyung-Nam.
Affiliation
  • Kim H; Department of Convergence Medicine and Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Republic of Korea.
  • Han M; Department of Convergence Medicine and Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Republic of Korea.
  • Kim M; Department of Convergence Medicine and Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Republic of Korea.
  • Kim H; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
  • Im HJ; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
  • Kim N; Department of Convergence Medicine and Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Republic of Korea.
  • Koh KN; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
Oncol Lett ; 25(6): 236, 2023 Jun.
Article de En | MEDLINE | ID: mdl-37153038
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Oncol Lett Année: 2023 Type de document: Article Pays de publication: Grèce
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Oncol Lett Année: 2023 Type de document: Article Pays de publication: Grèce